# Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

> **NCT05195372** · — · COMPLETED · sponsor: **Cardioangiologisches Centrum Bethanien** · enrollment: 80 (actual)

## Conditions studied

- Antiphospholipid Syndrome
- Venous Thromboembolism
- Arterial Thromboembolism
- Major Bleed

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05195372
- **Lead sponsor:** Cardioangiologisches Centrum Bethanien
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2022-04
- **Final completion:** 2022-07
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05195372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05195372, "Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05195372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*